Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
RESEARCH TOOLSreports
Holding CRNX?
Track your performance easily
Crinetics Pharmaceuticals (CRNX) Ownership Overview
7.36% Insiders
26.86% Mutual Funds
36.76% Other Institutional Investors
14.34% ETFs
14.67% Public Companies and
Individual Investors
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail, and individual investors. Approximately 77.97% of the company’s stock is owned by Institutional Investors, 7.36% is owned by Insiders, and 14.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 25, 2024 | Dana Pizzuti Chief Med And Dev Officer | xxxxxxxxxxxxx | $434435 |
| Apr 02, 2024 | Stephanie Okey Director | xxxxxxxxxxxxx | $811650 |
| Mar 26, 2024 | xxxxxxxxxxxxx | $1433675 | |
| Mar 22, 2024 | Dana Pizzuti Chief Med And Dev Officer | xxxxxxxxxxxxx | $664763 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $644626 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $24635258 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $37032067 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $59378200 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,495,143 | Institution | 7.00% | 364,312,571 | |
| 5,885,248 | Institution | 6.35% | 330,103,560 | |
| 3,727,952 | Insider | 5.60% | 209,100,828 | |
| 4,160,784 | Institution | 4.49% | 233,378,375 | |
| 3,448,845 | Institution | 3.72% | 193,445,716 | |
| 1,605,847 | Institution | 1.73% | 90,071,958 | |
| 1,385,580 | Institution | 1.49% | 77,717,182 | |
| 1,183,832 | Institution | 1.28% | 66,401,137 | |
| 1,162,000 | Institution | 1.25% | 65,176,580 | |
| 1,159,290 | Insider | 1.25% | 65,024,576 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,448,845 | Institution | 3.72% | 193,445,716 | |
| 1,605,847 | Institution | 1.73% | 90,071,958 | |
| 1,385,580 | Institution | 1.49% | 77,717,182 | |
| 1,053,750 | Institution | 1.14% | 59,104,838 | |
| 1,036,501 | Institution | 1.12% | 58,137,341 | |
| 1,012,628 | Institution | 1.09% | 56,798,305 | |
| 1,006,177 | Institution | 1.08% | 56,436,468 | |
| 960,171 | Institution | 1.04% | 53,855,991 | |
| 928,441 | Institution | 1.00% | 52,076,256 | |
| 871,759 | Institution | 0.94% | 48,896,962 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,695,825 | Institution | 2.91% | 150,858,367 | |
| 2,408,113 | Institution | 2.60% | 135,071,058 | |
| 1,338,230 | Institution | 1.44% | 74,887,351 | |
| 1,072,685 | Institution | 1.16% | 60,027,453 | |
| 1,037,304 | Institution | 1.12% | 58,151,262 | |
| 791,448 | Institution | 0.85% | 44,392,318 | |
| 590,050 | Institution | 0.64% | 33,019,198 | |
| 585,093 | Institution | 0.63% | 32,817,866 | |
| 435,473 | Institution | 0.47% | 24,412,616 | |
| 399,612 | Institution | 0.43% | 22,362,288 |
FAQ
Who Owns Crinetics Pharmaceuticals (CRNX)?
According to the latest TipRanks data, approximately 36.76% of the company's stock is held by institutional investors, 7.36% is held by insiders, and 14.67% is held by retail investors.
What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.76% of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors.
What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.67% of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors.
Who owns the most shares of Crinetics Pharmaceuticals (CRNX)?
Vanguard owns the most shares of Crinetics Pharmaceuticals (CRNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.